RABL3 New Rare Gene Mutation Discovered

RABL3 Inherited Pancreatic Cancer Risk Mutation Identified Original Source Dana-Farber Cancer Institute Modified For Style and Length This article originally appeared at the Dana-Farber Cancer Institute Scientists at the Dana-Farber

Study: Arming The Immune System To Recognize Foreign Invaders

New TGen Study To Combat Pancreatic Cancer The Seena Magowitz Foundation Releases $200,000 Toward A Total Grant of $1 Million To Fund The Study The Translational Genomics Research Institute (TGen), an

New Novel Way To Reverse Pancreatic Cancer

Scientists At Purdue University Reverse Pancreatic Cancer Progression In A “Time Machine” Made of Human Cells   Purdue University Engineers Have Shown A Novel Way To Reverse The Course of

Clinical Trial Funded By The Seena Magowitz Foundation

Announcing The Launch of “THE PANCREAS Clinical Trial” The “PANCREAS” Clinical Trial By the Medical College of Wisconsin and Partly Funded By The Seena Magowitz Foundation Contribting Writer Tony Subia

Combining CRP and CA19-9 In A Prognostic Score in PDAC

Combining CRP and CA19-9 in A Prognostic Score in PDAC Original Article: https://www.nature.com/articles/s41598-020-80778-0 Download PDF Helsinki University Hospital January 12, 2021 Creative Commons Attribution

Pancreatic Cancer Patients Respond To CD Immuontherapy

New Biomarker May Predict Which Patients Respond To CD40 Source: Penn Medicine Abramson Cancer Center News Release: February 4, 2021 Modified For Style and Length By The Seena Magowitz Foundation

Why PDCA Tumors Are So Resistant To Treatment

Why Pancreatic Cancer Tumors Are So Resistant To Treatment Source: Cold Spring Harbor Laboratory Based Upon Its Press Release. February 23, 2017 Edited For Style and Length The Primary Reason

PCDA Stroma Shell Protects Its Tumors

Dense Stroma Impedes Anti-Cancer Drugs From Their Target Researchers Were Able To Determine Which Signals Encourage Fibroblast Cells To Protect or Hinder The Tumor Article Based On Press Release (October,